LKT Laboratories, Inc,
BIM and mTOR expression levels predict outcome to #erlotinib in #LungCancer: http://ow.ly/VAn2g
BIM and mTOR expression levels predict outcome to #erlotinib in #LungCancer: http://ow.ly/VAn2g
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small https://t.co/FrHabUDbCY #hvhebron #onco [tex…
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer. http://www.ncbi.nlm.nih.g…